Pioneer studies by Lotan's group found that Gal-1 and Gal-3 are expressed in the cytoplasm of the majority of prostate cancer cell lines, except LNCaP which is the most studied human androgen-sensitive cell line. The gene discussed is LGALS3; the disease is prostate carcinoma.